Organisation paid for research Program year 2022 Source: CMS Open Payments

Hematology Oncology Associates of CNY

Neither a doctor nor a teaching hospital

Research payments

$187,629

29 payments

Through program year 2022, Hematology Oncology Associates of CNY is reported as receiving $187,629 in research payments, across 29 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$163,841	26
2021	Research	$23,788	3

Breakdown

Who paid Research payments · program years 2021–2022

Merck Sharp & Dohme Corporation $111,707 8 payments
Myriad Genetic Laboratories, Inc. $75,922 21 payments

Studies the money was for Research payments · program years 2021–2022

EndoPredict Extended Endocrine Trial (EXET) $75,922 21 payments
A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy SBRT with or without Pembrolizumab MK-3475 in Participants with Unresected Stage I or II Non-Small Cell Lung Cancer NSCLC KEYNOTE-867 $69,457 4 payments
A Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Pembrolizumab MK-3475 Lenvatinib E7080,MK-7902 Chemotherapy Compared with Standard of Care as First-line Intervention in Participants with Metastatic Esophageal Carcinoma $42,250 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.